Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000049054 | SCV000077067 | likely benign | Hereditary breast ovarian cancer syndrome | 2022-11-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000131973 | SCV000187031 | likely benign | Hereditary cancer-predisposing syndrome | 2015-04-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000131973 | SCV000908973 | likely benign | Hereditary cancer-predisposing syndrome | 2018-05-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001570063 | SCV001794266 | likely benign | not provided | 2021-03-22 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 20516115, 30257991, 30765603, 28781887, 33552952, 31131967, 17305420, 17453335, 12142080) |
Sharing Clinical Reports Project |
RCV000077629 | SCV000109432 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 1 | 2012-07-09 | no assertion criteria provided | clinical testing | |
Breast Cancer Information Core |
RCV000077629 | SCV000145581 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 1 | 2004-02-20 | no assertion criteria provided | clinical testing |